Nationwide Fund Advisors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-17,619
Closed -$64K 3286
2017
Q1
$64K Sell
17,619
-12,811
-42% -$54.1K ﹤0.01% 2941
2016
Q4
$147K Sell
30,430
-40,599
-57% -$1.21M ﹤0.01% 2743
2016
Q3
$3.28M Buy
71,029
+6,881
+11% +$388K 0.01% 1169
2016
Q2
$3.27M Buy
64,148
+28,864
+82% +$1.43M 0.01% 1149
2016
Q1
$1.5M Sell
35,284
-743
-2% -$37.9K 0.01% 1490
2015
Q4
$2.83M Buy
36,027
+78
+0.2% +$4.51K 0.01% 1205
2015
Q3
$1.46M Buy
35,949
+8,628
+32% +$457K 0.01% 1537
2015
Q2
$1.42M Buy
27,321
+17,177
+169% +$855K 0.01% 1648
2015
Q1
$472K Sell
10,144
-294
-3% -$15.3K ﹤0.01% 2261
2014
Q4
$468K Sell
10,438
-148
-1% -$6.22K ﹤0.01% 2219
2014
Q3
$412K Sell
10,586
-71
-0.7% -$2.79K ﹤0.01% 2320
2014
Q2
$451K Buy
10,657
+3,436
+48% +$126K ﹤0.01% 2318
2014
Q1
$258K Buy
7,221
+418
+6% +$14.1K ﹤0.01% 2373
2013
Q4
$220K Buy
+6,803
New +$202K ﹤0.01% 2643

Other funds holding ISEE

Nationwide Fund Advisors's ISEE Position: Q2 2017 in Review

Nationwide Fund Advisors sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2017, closing a stake of 17,619 shares — an estimated $64K sold.

Nationwide Fund Advisors first reported a position in ISEE in Q4 2013 and held it in 14 quarters. The position peaked at $3.28M in Q3 2016. 77 funds tracked by Wall St. Rank hold ISEE as of Q2 2017.

  • Nationwide Fund Advisors reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 17,619 IVERIC bio, Inc. Common Stock shares in Q2 2017, an estimated $64K.
  • Nationwide Fund Advisors first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 14 quarters.
  • Nationwide Fund Advisors's IVERIC bio, Inc. Common Stock position peaked at $3.28M in Q3 2016.
  • 77 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2017.

Based on Nationwide Fund Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.